Bio-Rad Laboratories BIO
NYSE BIO
$373.54 +9.27 (+2.55%)
At close: Aug 20, 2026 · 11:15 AM UTC

Bio-Rad Laboratories (BIO) Selling, General & Administrative (2009 - 2026)

Bio-Rad Laboratories (BIO) Selling, General & Administrative (2009 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Abbott Laboratories 200.20 Bn 194.60 Bn 7.27 Bn 4.03 Bn
2 Stryker 129.69 Bn 126.21 Bn 4.50 Bn 2.23 Bn
3 Medtronic 120.14 Bn 110.92 Bn 6.41 Bn 3.06 Bn
4 Boston Scientific 74.16 Bn 73.62 Bn 3.85 Bn 1.80 Bn
5 Edwards Lifesciences 52.68 Bn 48.43 Bn 1.35 Bn 561.20 Mn
6 Dexcom 34.57 Bn 32.62 Bn 830.00 Mn 358.70 Mn
7 GE HealthCare Technologies 34.09 Bn 31.98 Bn 2.18 Bn 1.12 Bn
8 Koninklijke Philips 26.49 Bn 23.17 Bn 4.55 Bn -179.00 Mn
9 Steris 23.19 Bn 22.70 Bn 684.20 Mn 369.70 Mn
10 Bio-Rad Laboratories 9.99 Bn 8.37 Bn 345.80 Mn 212.00 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 212.00 Mn
Mar 31, 2026 212.40 Mn
Dec 31, 2025 221.00 Mn
Sep 30, 2025 206.80 Mn
Jun 30, 2025 207.70 Mn
Mar 31, 2025 208.80 Mn
Dec 31, 2024 204.00 Mn
Sep 30, 2024 200.40 Mn
Jun 30, 2024 194.70 Mn
Mar 31, 2024 214.90 Mn
Dec 31, 2023 207.12 Mn
Sep 30, 2023 201.20 Mn
Jun 30, 2023 207.82 Mn
Mar 31, 2023 225.55 Mn
Dec 31, 2022 212.20 Mn
Sep 30, 2022 211.11 Mn
Jun 30, 2022 207.79 Mn
Mar 31, 2022 196.69 Mn
Dec 31, 2021 221.69 Mn
Sep 30, 2021 216.15 Mn